↓ Skip to main content

Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment

Overview of attention for article published in Respiratory Research, December 2011
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
102 Dimensions

Readers on

mendeley
78 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment
Published in
Respiratory Research, December 2011
DOI 10.1186/1465-9921-12-143
Pubmed ID
Authors

Arata Azuma, Yoshio Taguchi, Takashi Ogura, Masahito Ebina, Hiroyuki Taniguchi, Yasuhiro Kondoh, Moritaka Suga, Hiroki Takahashi, Koichiro Nakata, Atsuhiko Sato, Shoji Kudoh, Toshihiro Nukiwa, Pirfenidone Clinical Study Group in Japan

Abstract

A phase III trial in Japan showed that pirfenidone is effective for idiopathic pulmonary fibrosis (IPF). To find out which patients specifically benefit from pirfenidone, we analyzed in an exploratory manner the data from the phase III trial.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 78 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 3%
Denmark 1 1%
Unknown 75 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 19%
Other 12 15%
Student > Ph. D. Student 7 9%
Student > Master 7 9%
Student > Bachelor 6 8%
Other 15 19%
Unknown 16 21%
Readers by discipline Count As %
Medicine and Dentistry 47 60%
Agricultural and Biological Sciences 4 5%
Nursing and Health Professions 3 4%
Biochemistry, Genetics and Molecular Biology 2 3%
Business, Management and Accounting 1 1%
Other 5 6%
Unknown 16 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 November 2013.
All research outputs
#20,656,820
of 25,374,647 outputs
Outputs from Respiratory Research
#2,702
of 3,062 outputs
Outputs of similar age
#203,842
of 246,218 outputs
Outputs of similar age from Respiratory Research
#60
of 69 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,062 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.9. This one is in the 3rd percentile – i.e., 3% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 246,218 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 69 others from the same source and published within six weeks on either side of this one. This one is in the 4th percentile – i.e., 4% of its contemporaries scored the same or lower than it.